Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. - Wikidata - wikimedia - TriplyDB

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

http://www.wikidata.org/entity/Q36915151

about

Current advances in biomarkers for targeted therapy in triple-negative breast cancer Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.Loss of MutL Disrupts Chk2-dependent Cell Cycle Control Through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations.Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.Familial associations of female breast cancer with other cancers.Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.Mutations in context: implications of BRCA testing in diverse populations.Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds.Inherited Cancer in the Age of Next-Generation Sequencing.Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.Gene aberration profile of tumors of adolescent and young adult females.Identification of genetic variants for clinical management of familial colorectal tumors.Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility

P2860

Q28074202-4893A898-D66B-482C-B9EB-593B786625F6 Q33571034-D9B0E2EA-9F4C-45E5-955D-EBBDDDAA05B2 Q33784408-C275042B-D1BA-4CDA-B8C6-93F6382BB934 Q33823472-CEAE592C-88E5-4667-B809-A978C029B700 Q37686235-196144DE-1834-4C75-AB84-523DE27D0B67 Q38616483-F490E30F-4406-4983-B538-AA9AA4EE33AF Q38628334-C348D916-1877-4CE0-9148-EFFECAF6DDE8 Q38821634-737CEF55-5551-4E06-923C-EA925E2485EC Q38840457-225FD911-0D07-4950-98C8-74BC1B97AB49 Q38870541-EF2DF16B-7806-4779-ABF7-D4A21F10F087 Q38979257-6849B60B-5073-47A7-A564-6F1D7B92DE0E Q39393028-D1176229-792E-452A-900D-38351C9D5E34 Q39612960-B7F00D99-8C5B-498D-BE08-C88CF248FD63 Q40085390-D2C03B06-FAD2-4684-93E8-C0075C564335 Q40975746-7B21B0F5-26F9-45FF-9165-E6857A1AC3E5 Q41146968-6EC1FF91-8D57-4854-95C2-BB5DF4A92E1A Q42367527-61E556F1-6B14-427D-A408-80CAA6AE133A Q43821846-349C0AC2-8363-4289-AE1A-7FD5D377FA70 Q44813406-3EAF985E-593A-4DBD-8454-2EBCB3D12A7B Q46861405-BC269AFA-06A7-4856-B2BF-4AB922F0AED1 Q47110043-0108B6E0-1173-491C-8EC1-3DAE77C136F0 Q47191699-6C90894F-242D-4CC5-B8FC-E71B0C94DABF Q47260838-4313D827-E6F4-4178-9B2A-33849DFC1A5A Q47586106-25A41A05-9217-4878-9C45-4106358064F1 Q47691368-500FBB49-C7D6-4E9C-9CFC-60077630423D Q47763856-93FFE29D-C20A-4002-ABB7-248E86CAF694 Q48162236-CDEB82B5-4702-4A71-9EAD-64C4E0BFDD57 Q48258664-11E95897-00A7-45BD-939E-2F1B73937746 Q49166530-8FE4DE9B-A036-4201-906C-4328AE613E35 Q49573714-75672B98-26B8-4B12-A636-3E653E106E96 Q49787556-CB542F33-FDC6-485B-9D40-5800C6972061 Q49844031-4B9B1607-DEC4-44A5-9E7E-7E7274F01FF3 Q49993491-D7242C8C-51B8-4776-AB2C-88E0720FFDBA Q50033931-4B984517-D20D-4F29-A837-32DB4BBBE999 Q51162850-F56CE0B6-E621-48DF-9F9D-3738A9352740 Q55309832-D9A9646E-C1BA-4183-BCD4-F16B85163066 Q56395598-D1D89836-BBD0-431E-98CE-5FDA6A7E2C3B Q57930243-92A1C3DF-E820-4879-9A86-73B28DF60CD9 Q58792311-9AEDF60F-6B98-47B6-A351-8FDE914B49D3

P2860

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

http://www.wikidata.org/entity/Q36915151

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Frequency of Germline Mutation ...... f Patients With Breast Cancer.

@en

type

label

Frequency of Germline Mutation ...... f Patients With Breast Cancer.

@en

prefLabel

Frequency of Germline Mutation ...... f Patients With Breast Cancer.

@en

P1433

Q36915151-5F62F279-2E83-4644-87BC-228E01630692

P1476

Q36915151-2A34828E-6D26-4962-AF9F-92C7A45EC5C9

P2093

Q36915151-284E0FB6-C17E-45DB-AF35-5EB6E760D0BA

Q36915151-39578ED8-42D3-490D-895D-DBC2652456BA

Q36915151-3C677A8D-373B-4538-B8FB-9900AD69F72E

Q36915151-545610E1-BCE1-46C3-9D23-C02438DEA204

Q36915151-5F45AE8D-745D-41B1-A581-C18AEC7A2B2F

Q36915151-75D04BA9-4F77-4B1E-A264-A0F6959D9A16

Q36915151-9D3EA76D-ED56-46A6-AC44-FBC3F086C82C

Q36915151-D74667DC-8613-4C82-B400-6CA44EB5A585

Q36915151-FF4635C9-5859-4A45-87A6-3F55D5827390

P2860

Q36915151-0DE5A566-E373-4130-993E-08077D430153

Q36915151-156B69B1-17F3-48B3-B25A-39E4E669A40E

Q36915151-172673AF-88E7-40BF-A6F9-2FA1FBD60170

Q36915151-1BD3B1FD-C44C-4A80-9F62-F6B101CDFB97

Q36915151-1FAA009B-6926-40FE-B6C3-58850D025DFB

Q36915151-2974CD08-033D-484C-91FD-D764E6C6572E

Q36915151-2BD7DA2F-2EB7-4D92-8446-713766571AA3

Q36915151-31C3B5F2-343E-4C10-B745-1FC3950F7702

Q36915151-33824BFB-DCEE-408C-B3CF-7B8341F62BEE

Q36915151-33BB4E95-48A5-402D-BC4D-522E22A36040

P304

Q36915151-D3452177-6D76-4481-B631-409EC32EC7A3

P31

Q36915151-B41BC2C6-BEAF-42B6-B1AC-5BD512DA1F93

P356

Q36915151-53BA7DA9-CAA7-471C-8D0B-8636EF0DB2D9

P407

Q36915151-28AB2792-52CA-40CA-A89B-71B3EC085C12

P433

Q36915151-9B806DFE-4775-43B8-B9D2-BA9A3097616A

P478

Q36915151-F215F396-5E64-42C7-A8AD-2AE87455A42F

P577

Q36915151-1B8C18E3-D9AA-4ABA-8E8C-FBBDBD637A6B

P698

Q36915151-E6AD9559-8018-4542-9294-4779271C09BA

P932

Q36915151-F6F220B7-DB16-4700-A4C5-83E08C98D433

P356

JCO.2015.65.0747

P1433

Journal of Clinical Oncology

P1476

Frequency of Germline Mutation ...... f Patients With Breast Cancer.

@en

P2093

Anne-Renee Hartman

http://www.w3.org/2001/XMLSchema#string

Brian A Allen

http://www.w3.org/2001/XMLSchema#string

Eric P Winer

http://www.w3.org/2001/XMLSchema#string

John Kidd

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Nadine Tung

http://www.w3.org/2001/XMLSchema#string

Nancy U Lin

http://www.w3.org/2001/XMLSchema#string

Nanda Singh

http://www.w3.org/2001/XMLSchema#string

Richard J Wenstrup

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

Variation of breast cancer risk among BRCA1/2 carriers.

Meta-analysis of BRCA1 and BRCA2 penetrance

Repeated observation of breast tumor subtypes in independent gene expression data sets

Germline mutations in RAD51D confer susceptibility to ovarian cancer

Mutations in BRIP1 confer high risk of ovarian cancer

Genetic testing for RAD51C mutations: in the clinic and community

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

P304

1460-1468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.65.0747

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26976419

http://www.w3.org/2001/XMLSchema#string

P932

4872307

http://www.w3.org/2001/XMLSchema#string